• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Decision analysis in antibiotic therapy].

作者信息

Calvo M V, Domínguez-Gil A

机构信息

Servicio de Farmacia, Hospital Clínico Universitario, Salamanca.

出版信息

Enferm Infecc Microbiol Clin. 1990 Apr;8(4):199-207.

PMID:2128607
Abstract

Decision analysis constitutes a systematic approach for taking decisions in situations of uncertainty. This technique allows one to evaluate all therapeutic options and to quantify the possible results, with a view to selecting therapeutic regimens that have the best cost-effectivity relationship. Cost-benefict and cost-effectiveness studies have become increasingly more interesting in the evaluation of antibiotic therapy. In the present paper a review is offered of all factors that, both in antibiotic prophylaxis and the treatment of established infections, govern the cost-effectivity relationship of one's decisions. A review is also made of the methodology of decision analysis, whose use in antiinfective therapy seems sufficiently clear, specially as an objective criterion in the choice of antibiotics.

摘要

相似文献

1
[Decision analysis in antibiotic therapy].
Enferm Infecc Microbiol Clin. 1990 Apr;8(4):199-207.
2
Balancing the benefits and costs of antibiotic drugs: the TREAT model.平衡抗生素药物的效益和成本:TREAT 模型。
Clin Microbiol Infect. 2010 Dec;16(12):1736-9. doi: 10.1111/j.1469-0691.2010.03330.x.
3
[Analysis of the cost-effectiveness relationship in the empirical treatment in patients with infections of the lower respiratory tract acquired in the community].社区获得性下呼吸道感染患者经验性治疗中成本效益关系分析
Enferm Infecc Microbiol Clin. 2000 Nov;18(9):445-51.
4
It is money that matters: decision analysis and cost-effectiveness analysis.重要的是金钱:决策分析与成本效益分析。
Clin Orthop Relat Res. 2003 Aug(413):106-16. doi: 10.1097/01.blo.0000079326.41006.4e.
5
[Decision analysis and initiation of an "empiric" therapy].[决策分析与“经验性”治疗的启动]
Rev Med Brux. 1999 Feb;20(1):21-4.
6
A cost analysis of long term antibiotic prophylaxis for spontaneous bacterial peritonitis in cirrhosis.肝硬化患者自发性细菌性腹膜炎长期抗生素预防的成本分析
Am J Gastroenterol. 1998 Oct;93(10):1895-900. doi: 10.1111/j.1572-0241.1998.00545.x.
7
Economic impact of standard antibiotic therapy combined with amikacin, in clinical unit, Lodz, poland--part I.标准抗生素疗法联合阿米卡星在波兰罗兹临床科室的经济影响——第一部分
Acta Pol Pharm. 2005 Nov-Dec;62(6):485-90.
8
Economic impact of standard antibiotic therapy combined with amikacin, in clinical unit, Lodz, Poland--part II.标准抗生素疗法联合阿米卡星在波兰罗兹临床科室的经济影响——第二部分
Acta Pol Pharm. 2005 Nov-Dec;62(6):491-5.
9
Is antibiotic prophylaxis for bacterial endocarditis cost-effective?细菌性心内膜炎的抗生素预防是否具有成本效益?
Med Decis Making. 2005 May-Jun;25(3):308-20. doi: 10.1177/0272989X05276852.
10
The TREAT project: decision support and prediction using causal probabilistic networks.TREAT项目:使用因果概率网络的决策支持与预测
Int J Antimicrob Agents. 2007 Nov;30 Suppl 1:S93-102. doi: 10.1016/j.ijantimicag.2007.06.035. Epub 2007 Sep 24.